---

Usha Chakravarthy

Professor, Ophthalmology and Vision Sciences, Royal Victoria Hospital (The Belfast Trust) and Queens University of Belfast, Northern Ireland

Usha has been involved in many of the major international retinal clinical trials, including the IVAN, INTREPID, EUREYE, INDEYE, and V.I.S.I.O.N. studies, as well as co-authoring Cochrane Review articles and guidelines for the Royal College of Ophthalmologists on the treatment of AMD.

Notable achievements?

“Receiving a national honor (CBE) for services to ophthalmology, receiving the Alderman Award for macular degeneration research and being selected to deliver the Bowman lecture at the Royal College of Ophthalmologists.”

What is exciting you right now?

“The increasing awareness of the importance of neural cell health and not just the amelioration of exudative manifestations of AMD and diabetes, as well as the consideration of combined therapies to reduce neural cell loss.”

---

Part of the Power List 2018

100 reasons to be proud

This is the third time we have tried to map the Top 100 most influential people in the world of ophthalmology. The list includes surgeons, scientists, engineers, CEOs and more, and each one of them has been voted for by you, our readers.

Go to The Power List 2018